Want to see TSE:UDOC full AI Analyst Report?
Top Page
UniDoc Health Corp
(UDOC)
Select Model
Select Model
Rating:45Neutral
Price Target:
C$0.09
▲(10.00% Upside)
Action:Reiterated
Date:10/28/26
The score is held down primarily by weak financial performance—heavy losses, negative equity, and significant ongoing cash burn—despite some revenue traction and relatively low debt. Technicals are neutral with negative MACD and a long-term downtrend (below the 200-day average), while valuation is also constrained by losses (negative P/E) and no dividend yield support in the provided data.
Positive Factors
Revenue Traction
The strong reported revenue growth indicates that UniDoc is gaining initial commercial traction for its healthcare technology offering. Although the revenue base remains modest, continued expansion could improve operating leverage and establish a broader customer base over the next several quarters.
Negative Factors
Deep Unprofitability
UniDoc has not yet translated revenue traction into a sustainable earnings model. Large operating and net losses relative to revenue indicate that the current cost structure remains misaligned with sales, potentially requiring prolonged funding before profitability can be established.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Traction
The strong reported revenue growth indicates that UniDoc is gaining initial commercial traction for its healthcare technology offering. Although the revenue base remains modest, continued expansion could improve operating leverage and establish a broader customer base over the next several quarters.
Read all positive factors
UniDoc Health Corp (UDOC) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$7.77M
Dividend YieldN/A
Average Volume (3M)39.02K
Price to Earnings (P/E)―
Beta (1Y)1.24
Revenue Growth614.03%
EPS Growth51.97%
CountryCA
Employees5
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-0.04
Shares Outstanding86,350,090
10 Day Avg. Volume80,112
30 Day Avg. Volume39,018
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)-8.89
Price to Sales (P/S)9.89
P/FCF Ratio-3.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
UniDoc Health Corp Business Overview & Revenue Model
Company Description
Based in Vancouver, Canada, UniDoc Health Corp., established in 2021 and formerly known as Unicheck Holdings Corp. until April 2021, is a Canadian provider of virtual healthcare and telemedicine solutions. The company's core offering, "Virtual Hea...
UniDoc Health Corp Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
18
Very Negative
Cash Flow
10
Very Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 937.87K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 65.85K | -37.57K | -68.26K | -64.22K | 0.00 |
| EBITDA | -2.93M | -5.93M | -2.18M | -1.28M | -237.32K |
| Net Income | -3.23M | -6.06M | -2.26M | -1.36M | -237.32K |
Balance Sheet | |||||
| Total Assets | 1.56M | 2.91M | 517.08K | 320.47K | 288.40K |
| Cash, Cash Equivalents and Short-Term Investments | 273.37K | 1.25M | 398.88K | 51.32K | 281.84K |
| Total Debt | 26.39K | 68.68K | 74.86K | 94.79K | 200.00K |
| Total Liabilities | 2.60M | 2.24M | 2.38M | 1.22M | 425.13K |
| Stockholders Equity | -1.04M | 664.52K | -1.86M | -900.79K | -136.73K |
Cash Flow | |||||
| Free Cash Flow | -2.40M | -7.66M | -559.92K | -818.36K | 17.25K |
| Operating Cash Flow | -2.33M | -7.40M | -559.92K | -755.59K | 17.25K |
| Investing Cash Flow | -71.34K | -257.76K | 0.00 | -62.77K | 0.00 |
| Financing Cash Flow | 1.42M | 8.51M | 907.48K | 15.25K | 264.59K |
UniDoc Health Corp Technical Analysis
Positive
0.08
Price Trends
0.09
Positive
0.09
Positive
0.10
Negative
Market Momentum
>-0.01
Negative
53.79
Neutral
42.42
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:UDOC, the sentiment is Positive. The current price of 0.08 is above the 20-day moving average (MA) of 0.08, below the 50-day MA of 0.09, and below the 200-day MA of 0.10, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 53.79 is Neutral, neither overbought nor oversold. The STOCH value of 42.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:UDOC.
UniDoc Health Corp Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | C$467.36M | 62.14 | 2.79% | ― | 53.79% | 29.92% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
45 Neutral | C$7.77M | -2.39 | 355.56% | ― | 614.03% | 51.97% | |
44 Neutral | C$47.59M | -1.75 | -444.52% | ― | 415.06% | -54.80% | |
42 Neutral | C$2.39M | -0.82 | 184.91% | ― | ― | 43.30% | |
41 Neutral | C$10.29M | -1.76 | 64.52% | ― | 7.63% | -106.03% |
* Healthcare Sector Average
TSE:UDOC
UniDoc Health Corp
0.06
-0.13
-68.42%
TSE:VHI
Vitalhub
7.53
-3.50
-31.73%
TSE:AIDR
Rocket Doctor AI
0.46
-0.40
-46.51%
TSE:CHS
Comprehensive Healthcare Systems Inc
0.36
-0.20
-35.45%
TSE:NARA
PanGenomic Health, Inc. Class A
0.17
-1.04
-85.95%
UniDoc Health Corp Corporate Events
Financial DisclosuresRegulatory Filings and Compliance
UniDoc Health Updates Market on Audit Delay and Cease Trade Order
Negative
Sep 28, 2026
UniDoc Health Corp. has issued a bi-weekly update on its ongoing audit delay and related management cease trade order, confirming it is working closely with its auditor to complete its audited annual financial statements for the year ended March 3...
Business Operations and StrategyProduct-Related Announcements
UniDoc Health Powers San Juan Ambulance Telehealth with Upgraded Live Video System
Positive
Sep 17, 2026
The Department of Health for the Municipality of San Juan, Puerto Rico, is expanding its ambulance-based telehealth program using UniDoc Health’s UniDoc Connect platform across a fleet of 21 vehicles. The system combines a portable tablet wi...
Financial DisclosuresRegulatory Filings and Compliance
UniDoc Health Updates Investors on Audit Progress and Cease Trade Order
Negative
Aug 31, 2026
UniDoc Health Corp has issued a bi-weekly update on its management cease trade order, confirming ongoing work with its auditor to complete audited annual financial statements for the year ended March 31, 2026. The company reiterates its commitment...
Business Operations and StrategyProduct-Related Announcements
UniDoc Health Explores Remote Cardiac Screening Partnership with Ventripoint
Positive
Aug 20, 2026
UniDoc Health Corp. has signed a non-exclusive, non-binding memorandum of understanding with Ventripoint Diagnostics to explore integrating Ventripoint’s AI-driven VMS+ cardiac imaging platform into UniDoc’s Health Cubes and virtual-ca...
Financial DisclosuresRegulatory Filings and Compliance
UniDoc Health Begins Audit as Management Cease Trade Order Remains in Place
Negative
Aug 13, 2026
UniDoc Health Corp., a developer of remote eHealth consultation platforms, is focused on deploying and commercializing physical access points for virtual care in partnership with governments, institutions and organizations. The company aims to bui...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.